Related Experiment Video
Updated: Mar 9, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
Situational analysis of tuberculosis control programs in the Eastern Mediterranean Region: Gaps and solutions
1STOP Tuberculosis Unit, Directorate of Communicable Diseases, Eastern Mediterranean Regional Office, World Health Organization, Cairo, Egypt.
Objective/Background:
The objectives of this study were to highlight the key challenges and the strategic directions to scale-up tuberculosis (TB) care in the Eastern Mediterranean Region (EMR); to review TB burden in EMR, and evaluate the progress toward Millennium Development Goals (MDGs) targets by 2015; to identify the main obstacles for optimal TB care toward TB elimination; and to provide strategic directions to address the key challenges. The Eastern Mediterranean Region is composed of 22 countries with 648 million populations. The region has estimated TB incidence of 116 per 100,000. The estimated number of incident TB cases in 2015 was 749000 TB case.
Methods:
The paper is based on the Annual World Health Organization Global TB report on implementation of TB control strategy.
Results:
The EMR is a middle TB- and MDR-TB-burden region with 22 countries. As for MDGs, the region was able to meet the mortality target and revert TB incidence but could not achieve the prevalence target. The main challenges are limited infrastructure, human capacity, funds, use of new diagnostics tools and new medicines, and involvement of all stakeholders and community in TB care and control in addition to complex emergencies.
Conclusion:
The year 2015 marks a transition from the MDGs to the Sustainable Development Goals and from the Stop TB Strategy to the End TB Strategy. The region will move into three main directions: complete pending tasks, mitigate the impact of the complex emergencies on TB control, and move toward TB elimination.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Principles of Disease Surveillance

